from 10SB12G
1 page
[Article] 5 [Cik] 0000789097 [Name] Immunotechnology Corporation <table> <s> <c> <c> <c> [Period-Type] 9-Mos Year Year [Fiscal-Year-End] Jun-30-1998 Jun-30-1997 Jun-30-1996 [Period-End] Mar-31-1998 Jun-30-1997 Jun-30-1996 [Cash] 952 505 0 [Securities] 0 0 0 [Receivables] 0 0 0 [Allowances] 0 0 0 [Inventory] 0 0 0 [Current-Assets] 952 505 0 [PP&E] 0 0 0 [Depreciation] 0 0 0 [Total-Assets] 952 505 0 [Current-Liabilities] 18605 26,016 17,000 [Bonds] 0 0 0 [Preferred-Mandatory] 0 0 0 [Preferred] 0 0 0 [Common] 134,332 134,332 134,332 [Other-Se] (191,500) (166,393) (151,332) [Total-Liability-And-Equity] 952 505 0 [Sales] 0 0 0 [Total-Revenues] 0 0 0 [Cgs] 0 0 0 [Total-Costs] 0 0 0 [Other-Expenses] 23,216 15,061 0 [Loss-Provision] 0 0 0 [Interest-Expense] 1,891 0 0 [Income-Pretax] (25,107) (15,061) 0 [Income-Tax] 0 0 0 [Income-Continuing] 0 0 0 [Discontinued] 0 0 0 [Extraordinary] 0 0 0 [Changes] 0 0 0 [Net-Income] (25,107) (15,061) 0 [EPS-Primary] (0.02) (0.00) 0.00 [EPS-Diluted] (0.02) (0.00) 0.00 </Table>
